£ 1503.5
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Greatly undervalued vs peers
About
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on E
Target Price
The average target price of GSK.L is 1600 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
